Inclacumab (Anti-P-Selectin / CD62p)

Synonyms: Anti-Human selectin P Recombinant Antibody

Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.

Inclacumab (Anti-P-Selectin / CD62p)

Purity & Quality Control

Batch: A261601 Purity: 99% Protein concentration: 4.04mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.

Product Details

CAS No. 1256258-86-2
Molecular Weight 150
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) supplier | purchase Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) cost | Inclacumab (Anti-P-Selectin / CD62p) manufacturer | order Inclacumab (Anti-P-Selectin / CD62p) | Inclacumab (Anti-P-Selectin / CD62p) distributor